Brief: Promore Pharma: PRP Will Finance Development Of PXL01
May 7 (Reuters) - PROMORE PHARMA AB PROMO.ST :
* PROMORE PHARMA OUT-LICENSES PXL01 FOR SPINAL SURGERY TO
PHARMARESEARCH PRODUCTS LTD
* PRP WILL FINANCE DEVELOPMENT OF PXL01 FOR USE TO PREVENT
FIBROSIS AFTER SPINAL SURGERY
* PRP RECEIVED A GLOBAL COMMERCIAL LICENSE OF PXL01 FOR USE
IN
THIS INDICATION.
Source text for Eikon: ID:nWkrbnN10y
Further company coverage: PROMO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PMD Device Solutions AB
See all newsBrief: PMD Device Solutions Files For Bankruptcy
Brief: PMD Device Solutions Q3 EBITDA Loss Widens To SEK 8.9 Mln
Brief: Pmd Device Solutions Completes Sale Of Coala Life Monitor
Brief: PMDS’ Largest Shareholder Requests EGM To Appoint New Non-Executive Directors
Brief: PMDS Says RespiraSense Technology Demonstrates Capability In Predicting 7-Day Mortality